NASDAQ · Healthcare Plans · USD
Clover Health Investments, Corp. (CLOV) Stock Analysis
Clover Health Investments, Corp. (CLOV) is a Healthcare Plans stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CLOV Key Statistics
As of Oct 21, 2026Trading
- Open
- $4.86
- Previous Close
- $4.80
- Day's Range
- 4.70–4.90
- 52-Week Range
- 1.58–5.59
- Volume
- 3.18M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.46
Valuation
- Market Cap
- $2.55B
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 32.07
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.03
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.05
Financials (FY)
- Revenue (FY)
- $1.92B+40.34%
- Net Income (FY)
- −$85.55M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −0.74%
- Shares Outstanding
- 435.44M
- 1-Year Return
- +48.45%
Dividend and dates
- Earnings Date
- November 4, 2026
- Avg Volume
- 4.34M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CLOV closed at $4.78, +48.45% over 1 year.
Clover Health Investments, Corp. (CLOV) has a market capitalization of $2.55B.
In fiscal 2025, CLOV reported revenue of $1.92B.
CLOV Stock Return by Calendar Year
Clover Health Investments, Corp. (CLOV) return since Jun 2020: what $10,000 became
- 1 year
- $10,000 $14,845
- +48.45%
- 5 years
- $10,000 $6,081
- −39.19%
- Since Jun 2020
- $10,000 $4,686
- −53.14%
If you had invested $10,000 in Clover Health Investments, Corp. (CLOV) at the close on June 12, 2020, the earliest close on record here, it would have been worth $4,686 at the close on October 21, 2026: −53.14% in total, −11.24% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +103.40% |
| 2025 | −25.40% |
| 2024 | +230.88% |
| 2023 | +2.37% |
| 2022 | −75.00% |
| 2021 | −77.82% |
| 2020 (partial year) | +64.41% |
As of October 21, 2026.
CLOV Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.92B | −$85.55M | −4.4% |
| 2024 | $1.37B | −$43.01M | −3.1% |
| 2023 | $1.26B | −$213.36M | −16.9% |
| 2022 | $1.10B | −$339.57M | −31.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.92B | $355.90M | −$85.53M | −$85.55M | −4.4% |
| 2024 | $1.37B | $364.80M | −$45.46M | −$43.01M | −3.1% |
| 2023 | $1.26B | $255.95M | −$179.56M | −$213.36M | −16.9% |
| 2022 | $1.10B | $103.48M | −$286.66M | −$339.57M | −31.0% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CLOV Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | CLOV | Healthcare Plans median | vs median |
|---|---|---|---|
| P/S ratio | 1.03 | 0.38 | 170% above |
| Profit margin | −0.74% | 1.18% | 1.9 pts below |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
YahooClover Health: Star Plan Rating Buoys It - Why I'm (Cautiously) Long-Term Bullish
SeekingAlphaClover Health Investments (CLOV) Is Up 9.4% After Securing 5-Star PPO CMS Rating For 2027
YahooClover Health (CLOV) Stock Looks In Line Despite 5 Star Medicare News
YahooWhy Is Clover Health (CLOV) Stock Soaring Today
YahooIs Clover Health Stock Too Dependent On One Group Of Members?
Trefis
All 20 articles ↓Show fewer ↑
Clover Health Stock Pops: What's Happening?
BenzingaHumana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink
YahooClover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
YahooAt 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144
24/7 Wall St.Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
YahooClover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap?
YahooClover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
YahooUPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
YahooClover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
YahooClover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
MarketBeatAstrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
YahooALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
StocktwitsClover Health (CLOV) Gets New ‘Buy’ Call, Higher PT, Climbs 8.5%
YahooClover Health (CLOV) Shares Skyrocket, What You Need To Know
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$374.30B
CVSCVS Health Corporation
$119.52B
ELVElevance Health, Inc.
$94.15B
CIThe Cigna Group
$79.88B
HUMHumana Inc.
$51.08B
CNCCentene Corporation
$34.16B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
MRKMerck & Co., Inc.
$369.78B
NVSNovartis AG
$292.58B













